SCHEMBL4032826

SCHEMBL4032826

Cc1ccc(-n2c(C=O)cnc2S)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 1/20 0.36
ALPG P10696 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
KMT2A Q03164 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CYP2A6 P11509 1/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPC1 O15118 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HPGD P15428 1/20 0.35
XBP1 P17861 1/20 0.35
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14249127 0.83 PTGS2 (0.34) ALDH1A1MEN1CYP2C19KMT2ATSHR
SCHEMBL4036613 0.72 NOTUM (0.44) ALDH1A1KDM4EMEN1CYP2C19KMT2A
SCHEMBL8287013 0.71 KDM4E (0.41) ALDH1A1KDM4EMEN1ALPGCYP2C9
SCHEMBL27401270 0.70 AVPR1A (0.43) ALDH1A1MEN1CYP2C9KMT2ATSHR
SCHEMBL6593121 0.68 AVPR1A (0.53) ALDH1A1KDM4ECYP2C9CYP2C19TSHR
SCHEMBL4035995 0.67 IDO1 (0.49) ALDH1A1KDM4ECYP2C9CYP2C19L3MBTL1
SCHEMBL9039798 0.67 ALDH1A1 (0.41) ALDH1A1KDM4EMEN1ALPGCYP2C9
SCHEMBL3830999 0.67 PTGS2 (0.52) ALDH1A1KDM4EMEN1CYP2C9CYP2C19
SCHEMBL27567953 0.67 KDM4E (0.40) ALDH1A1KDM4EMEN1ALPGCYP2C9
SCHEMBL13080930 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1722785-A4 ION CHANNEL MODULATORS WYETH CORP (US) 2009-07-08 EP disclosed
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed
US-20070208064-A1 Ion channel modulators WYETH (US) 2007-09-06 US disclosed
US-20070208064-A1 Ion channel modulators WYETH (US) 2007-09-06 US disclosed
US-20070208064-A1 Ion channel modulators WYETH (US) 2007-09-06 US disclosed
EP-1722785-A1 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2006-11-22 EP disclosed
EP-1723117-A2 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2006-11-22 EP disclosed
WO-2005087228-A1 ION CHANNEL MODULATORS WYETH (US) 2005-09-22 WO disclosed
WO-2005087228-A1 ION CHANNEL MODULATORS WYETH (US) 2005-09-22 WO disclosed
WO-2005086836-A2 ION CHANNEL MODULATORS WYETH (US) 2005-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281937-A1 Ion Channel Modulators CACNA1B, CACNA1C, TRPV1 ALDH1A1 3706/4885KDM4E 3120/4885MEN1 3147/4885
US-20070208064-A1 Ion channel modulators CACNA1B, CACNA1C, TRPV1 ALDH1A1 3706/4885KDM4E 3120/4885MEN1 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.